oditrasertib   Click here for help

GtoPdb Ligand ID: 12372

Synonyms: example 29 [WO2018213632A1]
Compound class: Synthetic organic
Comment: This is the chemical structure for the INN oditrasertib. The structure is claimed in Denali Therapeutics' patent WO2018213632A1 [1].
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 4
Hydrogen bond donors 0
Rotatable bonds 3
Topological polar surface area 66.22
Molecular weight 295.11
XLogP 0.97
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES N#Cc1cncc2c1OCCN(C2)C(=O)C(C(F)F)(C)C
Isomeric SMILES CC(C)(C(F)F)C(=O)N1CCOc2c(cncc2C1)C#N
InChI InChI=1S/C14H15F2N3O2/c1-14(2,12(15)16)13(20)19-3-4-21-11-9(5-17)6-18-7-10(11)8-19/h6-7,12H,3-4,8H2,1-2H3
InChI Key CSCLQCHKUAMZOY-UHFFFAOYSA-N
References
1. Fidalgo J, Estrada AA, Feng JA, Fox B, Francini CM, Hale CRH, Hu C, Leslie CP, Osipov M, Serra E et al.. (2018)
Kinase inhibitors and uses thereof.
Patent number: WO2018213632A1. Assignee: Denali Therapeutics Inc.. Priority date: 17/08/2018. Publication date: 22/11/2018.